BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 26437436)

  • 21. ADAR editing in double-stranded UTRs and other noncoding RNA sequences.
    Hundley HA; Bass BL
    Trends Biochem Sci; 2010 Jul; 35(7):377-83. PubMed ID: 20382028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine Deaminases Acting on RNA (ADARs) and Viral Infections.
    Pfaller CK; George CX; Samuel CE
    Annu Rev Virol; 2021 Sep; 8(1):239-264. PubMed ID: 33882257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenosine-to-Inosine RNA Editing Enzyme ADAR and microRNAs.
    Yuting K; Ding D; Iizasa H
    Methods Mol Biol; 2021; 2181():83-95. PubMed ID: 32729076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-wide quantification of ADAR adenosine-to-inosine RNA editing activity.
    Roth SH; Levanon EY; Eisenberg E
    Nat Methods; 2019 Nov; 16(11):1131-1138. PubMed ID: 31636457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A-to-I editing of protein coding and noncoding RNAs.
    Mallela A; Nishikura K
    Crit Rev Biochem Mol Biol; 2012; 47(6):493-501. PubMed ID: 22988838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. irCLASH reveals RNA substrates recognized by human ADARs.
    Song Y; Yang W; Fu Q; Wu L; Zhao X; Zhang Y; Zhang R
    Nat Struct Mol Biol; 2020 Apr; 27(4):351-362. PubMed ID: 32203492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA Editing by ADAR Adenosine Deaminases: From Molecular Plasticity of Neural Proteins to the Mechanisms of Human Cancer.
    Goncharov AO; Kliuchnikova AA; Nasaev SS; Moshkovskii SA
    Biochemistry (Mosc); 2019 Aug; 84(8):896-904. PubMed ID: 31522671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The origin of the ADAR gene family and animal RNA editing.
    Grice LF; Degnan BM
    BMC Evol Biol; 2015 Jan; 15(1):4. PubMed ID: 25630791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA binding-independent dimerization of adenosine deaminases acting on RNA and dominant negative effects of nonfunctional subunits on dimer functions.
    Valente L; Nishikura K
    J Biol Chem; 2007 Jun; 282(22):16054-61. PubMed ID: 17428802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADARs: allies or enemies? The importance of A-to-I RNA editing in human disease: from cancer to HIV-1.
    Gallo A; Locatelli F
    Biol Rev Camb Philos Soc; 2012 Feb; 87(1):95-110. PubMed ID: 21682836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of substrates for adenosine deaminases that act on RNA.
    Morse DP
    Methods Mol Biol; 2004; 265():199-218. PubMed ID: 15103075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.
    Mannion NM; Greenwood SM; Young R; Cox S; Brindle J; Read D; Nellåker C; Vesely C; Ponting CP; McLaughlin PJ; Jantsch MF; Dorin J; Adams IR; Scadden AD; Ohman M; Keegan LP; O'Connell MA
    Cell Rep; 2014 Nov; 9(4):1482-94. PubMed ID: 25456137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editor meets silencer: crosstalk between RNA editing and RNA interference.
    Nishikura K
    Nat Rev Mol Cell Biol; 2006 Dec; 7(12):919-31. PubMed ID: 17139332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asymmetric dimerization of adenosine deaminase acting on RNA facilitates substrate recognition.
    Thuy-Boun AS; Thomas JM; Grajo HL; Palumbo CM; Park S; Nguyen LT; Fisher AJ; Beal PA
    Nucleic Acids Res; 2020 Aug; 48(14):7958-7972. PubMed ID: 32597966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ADAR RNA Modifications, the Epitranscriptome and Innate Immunity.
    Quin J; Sedmík J; Vukić D; Khan A; Keegan LP; O'Connell MA
    Trends Biochem Sci; 2021 Sep; 46(9):758-771. PubMed ID: 33736931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current strategies for Site-Directed RNA Editing using ADARs.
    Montiel-Gonzalez MF; Diaz Quiroz JF; Rosenthal JJC
    Methods; 2019 Mar; 156():16-24. PubMed ID: 30502398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of binding domains for dsRNA and Z-DNA in the in vivo editing of minimal substrates by ADAR1.
    Herbert A; Rich A
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12132-7. PubMed ID: 11593027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses.
    Samuel CE
    J Biol Chem; 2019 Feb; 294(5):1710-1720. PubMed ID: 30710018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide A-to-I RNA editing in fungi independent of ADAR enzymes.
    Liu H; Wang Q; He Y; Chen L; Hao C; Jiang C; Li Y; Dai Y; Kang Z; Xu JR
    Genome Res; 2016 Apr; 26(4):499-509. PubMed ID: 26934920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteome diversification by adenosine to inosine RNA editing.
    Pullirsch D; Jantsch MF
    RNA Biol; 2010; 7(2):205-12. PubMed ID: 20200492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.